Tiapride in levodopa-induced involuntary movements.
AUTOR(ES)
Lees, A J
RESUMO
Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa-induced peak dose involuntary movements in 16 patients with idiopathic Parkinson's disease. However, an unacceptable increase in disability from Parkinsonism with aggravation of end-of-dose akinesia led to its cessation in 14 patients. Tiapride had no effect on levodopa-induced early morning of "off-period" segmental dystonia. These results fail to support the notion that levodopa-induced dyskinesias are caused by overstimulation of a separate group of dopamine receptors.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=490211Documentos Relacionados
- Levodopa-induced dyskinesia and thalamotomy.
- Sodium valproate in the treatment of levodopa-induced dyskinesia.
- Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
- Levodopa‐induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
- Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease